171 related articles for article (PubMed ID: 22157260)
1. 2-hydroxy-4'-methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma.
Liu CS; Chang CC; Du YC; Chang FR; Wu YC; Chang WC; Hsieh TJ
J Cardiovasc Pharmacol; 2012 Apr; 59(4):339-51. PubMed ID: 22157260
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression.
Chang WC; Yu YM; Chiang SY; Tseng CY
Br J Nutr; 2008 Apr; 99(4):709-14. PubMed ID: 18184451
[TBL] [Abstract][Full Text] [Related]
3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells.
Chatterjee S; Bhunia AK; Snowden A; Han H
Glycobiology; 1997 Jul; 7(5):703-10. PubMed ID: 9254052
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
Duan SZ; Usher MG; Mortensen RM
Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
[TBL] [Abstract][Full Text] [Related]
6. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
8. [Green tea polyphenols inhibit low-density lipoprotein-induced proliferation of rat vascular smooth muscle cells].
Ouyang P; Peng WL; Lai WY; Xu AL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):975-9. PubMed ID: 15447839
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells.
Lim Y; Tudev M; Park ES; Kim WS; Lim IH; Lee MY; Lee H; Jung JK; Hong JT; Yoo HS; Lee MK; Pyo MY; Yun YP
Arch Pharm Res; 2011 Jul; 34(7):1191-9. PubMed ID: 21811927
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
Bedel A; Nègre-Salvayre A; Heeneman S; Grazide MH; Thiers JC; Salvayre R; Maupas-Schwalm F
Circ Res; 2008 Sep; 103(7):694-701. PubMed ID: 18703780
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.
Chahine MN; Deniset J; Dibrov E; Hirono S; Blackwood DP; Austria JA; Pierce GN
Cardiovasc Res; 2011 Dec; 92(3):476-83. PubMed ID: 22072707
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors.
Lin SJ; Shyue SK; Shih MC; Chu TH; Chen YH; Ku HH; Chen JW; Tam KB; Chen YL
Atherosclerosis; 2007 Jan; 190(1):124-34. PubMed ID: 16600249
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
16. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
[TBL] [Abstract][Full Text] [Related]
18. SDF-1 promotes ox-LDL induced vascular smooth muscle cell proliferation.
Li LX; Zhang XF; Bai X; Tong Q
Cell Biol Int; 2013 Sep; 37(9):988-94. PubMed ID: 23658061
[TBL] [Abstract][Full Text] [Related]
19. Ceramide 1-phosphate induces neointimal formation via cell proliferation and cell cycle progression upstream of ERK1/2 in vascular smooth muscle cells.
Kim TJ; Kang YJ; Lim Y; Lee HW; Bae K; Lee YS; Yoo JM; Yoo HS; Yun YP
Exp Cell Res; 2011 Aug; 317(14):2041-51. PubMed ID: 21624361
[TBL] [Abstract][Full Text] [Related]
20. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
